These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 9122277

  • 1. [Lipoamino acids and lipopeptides as potential 5- and 12-lipoxygenase inhibitors].
    Presenz P.
    Pharmazie; 1997 Feb; 52(2):164-5. PubMed ID: 9122277
    [No Abstract] [Full Text] [Related]

  • 2. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
    Bhatia PA, Brooks CD, Basha A, Ratajczyk JD, Gunn BP, Bouska JB, Lanni C, Young PR, Bell RL, Carter GW.
    J Med Chem; 1996 Sep 27; 39(20):3938-50. PubMed ID: 8831760
    [Abstract] [Full Text] [Related]

  • 3. [Pyrano[3,4-c]quinolines from 1-desaza--oxa-nifedipine].
    Görlitzer K, Trittmacher J, Jones PG, Frohberg P, Drutkowski G.
    Pharmazie; 2003 Aug 27; 58(8):539-42. PubMed ID: 12967028
    [Abstract] [Full Text] [Related]

  • 4. [Inhibition of the arachidonic acid cascade by aza-2-aryl-1,4-naphthoquinone derivatives].
    Richwien A, Wurm G.
    Pharmazie; 2004 Dec 27; 59(12):906-12. PubMed ID: 15638076
    [Abstract] [Full Text] [Related]

  • 5. 1'-Hydroxyeugenol- and coniferyl alcohol derivatives as effective inhibitors of 5-lipoxygenase and Cu(2+)-mediated low density lipoprotein oxidation. Evidence for a dual mechanism.
    Deigner HP, Wolf G, Ohlenmacher U, Reichling J.
    Arzneimittelforschung; 1994 Aug 27; 44(8):956-61. PubMed ID: 7945541
    [Abstract] [Full Text] [Related]

  • 6. [Pyrrolo(2,3-c)quinolines and pyrrolo(3,4-d)quinolines--synthesis and investigation of lipoxygenase inhibition].
    Görlitzer K, Fabian J, Frohberg P, Drutkowski G.
    Pharmazie; 2002 Apr 27; 57(4):243-9. PubMed ID: 11998442
    [Abstract] [Full Text] [Related]

  • 7. Chamazulene: an antioxidant-type inhibitor of leukotriene B4 formation.
    Safayhi H, Sabieraj J, Sailer ER, Ammon HP.
    Planta Med; 1994 Oct 27; 60(5):410-3. PubMed ID: 7997466
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and 5-lipoxygenase inhibitory activity of new cinnamoyl and caffeoyl clusters.
    Doiron J, Boudreau LH, Picot N, Villebonet B, Surette ME, Touaibia M.
    Bioorg Med Chem Lett; 2009 Feb 15; 19(4):1118-21. PubMed ID: 19152786
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
    Kirchner T, Argentieri DC, Barbone AG, Singer M, Steber M, Ansell J, Beers SA, Wachter MP, Wu W, Malloy E, Stewart A, Ritchie DM.
    J Pharmacol Exp Ther; 1997 Aug 15; 282(2):1094-101. PubMed ID: 9262379
    [Abstract] [Full Text] [Related]

  • 10. 5-Lipoxygenase inhibitors: convenient synthesis of 4-[3-(4-heterocyclylphenylthio)phenyl]-3,4,5,6-tetrahydro-2H-pyran-4-carboxamide analogues.
    Mano T, Stevens RW, Okumura Y, Kawai M, Okumura T, Sakakibara M.
    Bioorg Med Chem Lett; 2005 May 16; 15(10):2611-5. PubMed ID: 15863327
    [Abstract] [Full Text] [Related]

  • 11. Lipoxygenase inhibitors from natural plant sources. Part 1: Medicinal plants with inhibitory activity on arachidonate 5-lipoxygenase and 5-lipoxygenase[sol ]cyclooxygenase.
    Schneider I, Bucar F.
    Phytother Res; 2005 Feb 16; 19(2):81-102. PubMed ID: 15852496
    [Abstract] [Full Text] [Related]

  • 12. Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of arachidonate 5-lipoxygenase.
    Ghosh J.
    Biochem Biophys Res Commun; 2004 Mar 12; 315(3):624-35. PubMed ID: 14975747
    [Abstract] [Full Text] [Related]

  • 13. Diphyllin acetylapioside, a 5-lipoxygenase inhibitor from Haplophyllum hispanicum.
    Prieto JM, Giner RM, Recio Mf MC, Schinella G, Máñez S, Ríos JL.
    Planta Med; 2002 Apr 12; 68(4):359-60. PubMed ID: 11988863
    [Abstract] [Full Text] [Related]

  • 14. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.
    Matsuyama M, Yoshimura R, Mitsuhashi M, Hase T, Tsuchida K, Takemoto Y, Kawahito Y, Sano H, Nakatani T.
    Int J Oncol; 2004 Apr 12; 24(4):821-7. PubMed ID: 15010818
    [Abstract] [Full Text] [Related]

  • 15. 5-Methylflavasperone and rhamnetin from Guiera senegalensis and their antioxidative and 5-lipoxygenase inhibitory activity.
    Bucar F, Resch M, Bauer R, Burits M, Knauder E, Schubert-Zsilavecz M.
    Pharmazie; 1998 Dec 12; 53(12):875-8. PubMed ID: 9879572
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of leukotriene production by inhibitors of lipoxygenation.
    Garland LG, Hodgson ST.
    Adv Prostaglandin Thromboxane Leukot Res; 1994 Dec 12; 22():33-48. PubMed ID: 7771347
    [No Abstract] [Full Text] [Related]

  • 17. Role of 5-lipoxygenase pathway in the regulation of RAW 264.7 macrophage proliferation.
    Nieves D, Moreno JJ.
    Biochem Pharmacol; 2006 Oct 16; 72(8):1022-30. PubMed ID: 16934759
    [Abstract] [Full Text] [Related]

  • 18. Baicalein induction of hydroxyl radical formation via 12-lipoxygenase in human platelets: an ESR study.
    Chou DS, Lee JJ, Hsiao G, Hsieh CY, Tsai YJ, Chen TF, Sheu JR.
    J Agric Food Chem; 2007 Feb 07; 55(3):649-55. PubMed ID: 17263456
    [Abstract] [Full Text] [Related]

  • 19. Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase.
    Cho H, Ueda M, Tamaoka M, Hamaguchi M, Aisaka K, Kiso Y, Inoue T, Ogino R, Tatsuoka T, Ishihara T.
    J Med Chem; 1991 Apr 07; 34(4):1503-5. PubMed ID: 2016727
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis of celecoxib analogues possessing a N-difluoromethyl-1,2-dihydropyrid-2-one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
    Chowdhury MA, Abdellatif KR, Dong Y, Das D, Suresh MR, Knaus EE.
    J Med Chem; 2009 Mar 26; 52(6):1525-9. PubMed ID: 19296694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.